Record No:1


ACCESS NOD109516
GENE_NAMEFURIN
DESCRIPTIONFurin, paired basic amino acid cleaving enzyme
ALIASESFUR, PACE, PCSK3, SPC1.
NCBI_ENTREZ_NO5045
UNIPROT_ACCESS_NOP09958
ORGANISMHuman
DISEASE_PHENOTYPEAsthma, Allergic Rhinitis
SAMPLECD4 T cells
TECHNIQUESRNA Sequencing
OMICSTranscriptomics
STUDYHigh Throughput
GEO_PRIDE_ACCESS_NOGSE75011
COMMENTSFURIN was significantly decreased in asthmatics as compared to healthy subjects.
REFERENCE27271570
IMMUNITY_TERMNo
GO_MOLECULAR_FUNCTIONProtease binding, endopeptidase activity, serine-type endopeptidase activity, serine-type endopeptidase inhibitor activity, protein binding, peptidase activity, serine-type peptidase activity, hydrolase activity, peptide binding, metal ion binding, nerve growth factor binding.
GO_BIOLOGICAL_PROCESSSignal peptide processing, proteolysis, transforming growth factor beta receptor signaling pathway, regulation of signal transduction, negative regulation of endopeptidase activity, protein processing, peptide hormone processing, viral life cycle, viral protein processing, extracellular matrix disassembly, extracellular matrix organization, collagen catabolic process, zymogen activation, nerve growth factor processing, negative regulation of low-density lipoprotein particle receptor catabolic process, nerve growth factor production, NOT negative regulation of nerve growth factor production, negative regulation of transforming growth factor beta 1 production, secretion by cell, regulation of protein catabolic process, peptide biosynthetic process, cellular protein metabolic process, regulation of low-density lipoprotein particle receptor biosynthetic process, regulation of lipoprotein lipase activity, positive regulation of membrane protein ectodomain proteolysis, regulation of endopeptidase activity, cornification, dibasic protein processing, positive regulation of transforming growth factor beta1 activation.
BIOGRID_INTERACTION_ID111082
SNP_ID-
DRUG_ID-
STRUCTURE_ID207583
207584
MONOCLONAL_ANTIBODYAnti-Furin antibody for Human, Mouse, Rat.